Trial ID or NCT#

NCT01898598

Status

NOT RECRUITING

Purpose

This randomized, double-blind, placebo-controlled study will assess the efficacy and safety of vismodegib with surgery in participants with basal cell carcinoma.

Official Title

A Randomized, Double-Blind, Placebo-Controlled, Phase II Study to Assess the Efficacy and Safety of Oral Vismodegib for the Treatment of Basal Cell Carcinoma Preceding Excision by Mohs Micrographic Surgery

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Sumaira Z. Aasi, MD
Dermatologist, Mohs surgeon, Cutaneous oncology specialist, Surgical oncologist
Clinical Professor, Dermatology Clinical Professor (By courtesy), Surgery - Plastic & Reconstructive Surgery

Contact us to find out if this trial is right for you.

CONTACT

CCTO
(650) 498-7061